about
Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studiesMeasuring health system strengthening: application of the balanced scorecard approach to rank the baseline performance of three rural districts in ZambiaDevelopment of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studiesComparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South AfricaMalaria at Christmas: risks of prophylaxis versus risks of malaria.Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia.The association between household socioeconomic position and prevalent tuberculosis in Zambia: a case-control study.Linezolid-resistant enterococci: report of the first isolates in the United Kingdom.Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia.High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa.Protocol-driven primary care and community linkages to improve population health in rural Zambia: the Better Health Outcomes through Mentoring and Assessment (BHOMA) projectSystems thinking in practice: the current status of the six WHO building blocks for health system strengthening in three BHOMA intervention districts of Zambia: a baseline qualitative studyMeasuring governance at health facility level: developing and validation of simple governance tool in Zambia.The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alertPrevalence and correlates of alcohol dependence disorder among TB and HIV infected patients in Zambia.Effect of home-based interventions on virologic outcomes in adults receiving antiretroviral therapy in Africa: a meta-analysisScreening for tuberculosis and testing for human immunodeficiency virus in Zambian prisonsCan we control tuberculosis in high HIV prevalence settings?The sensitivity and specificity of using a computer aided diagnosis program for automatically scoring chest X-rays of presumptive TB patients compared with Xpert MTB/RIF in Lusaka Zambia.Application of balanced scorecard in the evaluation of a complex health system intervention: 12 months post intervention findings from the BHOMA intervention: a cluster randomised trial in ZambiaHIV treatment-as-prevention research: taking the right road at the crossroadsImplementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained SettingsChanges in tuberculosis notifications and treatment delay in Zambia when introducing a digital X-ray service.Frequency of HIV-testing and factors associated with multiple lifetime HIV-testing among a rural population of Zambian men.Symptom reporting among prevalent tuberculosis cases who smoke, are HIV-positive or have hyperglycaemia.Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.Isoniazid to prevent first and recurrent episodes of TB.Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative.Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa.Measuring health workers' motivation in rural health facilities: baseline results from three study districts in Zambia.A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London.ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trialCan combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and ZambiaPrevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIVSensitivity, specificity, and reproducibility of the Capilia TB-Neo assayHPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical modelHPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.
P50
Q26798073-1A7A913B-D763-4621-875B-F1B91A2F240CQ28488701-1C275122-C987-43D3-B28E-6E22E3E41201Q28743478-48654ADA-37F9-4A6F-80F6-8113102689DEQ31043943-92CA9340-96E7-49E1-B23C-F01FA055BC85Q33344474-3529F6F7-FE90-490C-818A-B10476A69389Q33516016-5D6D7406-17E2-45BC-BC71-C167B1AF6B02Q33792782-73DFFDB0-5EFA-4227-8858-C9CAF0471EFCQ33869437-2188FD5F-3B73-4CDE-8BEE-CE63CED68527Q33890003-42BD3C92-F9D4-4902-AD0E-8D252F7740FEQ33940770-949BA9F6-676C-482A-B2AC-1A4666990848Q34156889-1899B62D-0538-4DF0-9501-F12BC8EBA586Q34369989-EFE3B425-DBC2-43E2-B15C-EF379AABB7E9Q34656147-2FE84575-8088-4C2B-9E23-4D460586A92AQ34790256-CE11AEA8-0D9D-4348-B299-186DF9DA0CF5Q34884042-92234444-5C1B-4248-AC02-A1226009999AQ34910994-6EA9C6DB-ED47-4259-AE12-2995AE6F01D1Q34962152-B4E53E18-7760-4604-95DA-A8DF0BBE958BQ34999178-FA90A06E-5208-40B6-8950-97A2038E084EQ35114171-C8D73D8D-81F6-406E-82D6-8BFF416A0138Q35119993-DB0566A2-0C6B-44A7-8E0E-A89D58100FB4Q35132006-9AA77886-5A30-45C2-86CB-E7E2F5068446Q35140397-D6547ACB-0649-4A9D-B2D6-32A0E55F9DCFQ35153941-87BEB55E-80A6-4279-916A-EF0D1A862034Q35164755-BAA00ECD-1BD2-4862-AD66-4515F0071325Q35647887-BBE694DA-64A1-4942-9306-3E28E714FF98Q35718626-4F271887-4CC1-45C8-9271-EAFF67D9E787Q35787310-F165CB58-1F70-4A35-8B62-8C914CD4B204Q35944019-7728B58C-8DCF-4217-9D34-69A5793241EDQ36446258-72E3520F-CDE4-44EC-A604-63D4B34745ACQ36447646-5C985FF3-D896-4098-9FBC-952C4CD5F374Q36493894-3FC03D80-0D2D-49B3-A62C-179107557001Q36617152-77884019-F5FF-40EE-8B96-9801A0390EF7Q36716497-B9E87318-47B7-448D-9B91-2CD5CF8F07BFQ36823063-B39B633D-EB80-4F54-B5A9-C2D3A29BAA0EQ36979131-0CEAECFA-CA78-4A9B-B8AA-218C226A8EA8Q37083998-068782E4-61E9-404E-840C-A4BCB81CDA3AQ37186681-B2D3FF28-E422-4627-B5C3-ACDCBE7DB533Q37336281-C49C1F0D-F028-4543-8DBD-969EE9CF69B1Q37483779-9743425A-9459-47B3-BB66-F08D42D4FCBDQ37593498-7BAF5A39-E30B-4CC7-8021-7AE97B1764C7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helen Ayles
@ast
Helen Ayles
@en
Helen Ayles
@es
Helen Ayles
@nl
Helen Ayles
@sl
type
label
Helen Ayles
@ast
Helen Ayles
@en
Helen Ayles
@es
Helen Ayles
@nl
Helen Ayles
@sl
prefLabel
Helen Ayles
@ast
Helen Ayles
@en
Helen Ayles
@es
Helen Ayles
@nl
Helen Ayles
@sl
P106
P21
P31
P496
0000-0003-4108-2842